Literature DB >> 9860114

Excitotoxic lesions of the mediodorsal thalamic nucleus attenuate intravenous cocaine self-administration.

R Weissenborn1, R B Whitelaw, T W Robbins, B J Everitt.   

Abstract

The present experiments investigated the effects of excitotoxic, axon-sparing lesions of the mediodorsal nucleus of the thalamus (MD) on locomotor activity and i.v. cocaine self-administration. Infusion of quinolinic acid into the MD using a glass micropipette produced well-defined neuronal loss restricted to medial and lateral portions of the MD, sparing adjacent areas such as the lateral habenula and paraventricular thalamic nucleus. MD lesions resulted in delayed habituation to activity cages. In addition, lesioned rats self-administered significantly smaller amounts of cocaine than controls during a 14-day acquisition period, and showed attenuated responding for cocaine doses on the descending limb of the dose-effect function. Since typical titrating patterns of responding were maintained in lesioned rats, and responding on the inactive lever did not differ from sham-operated animals, these present results indicate an enhanced sensitivity to the reinforcing effects of response-contingent cocaine in rats with excitotoxic lesions of the MD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9860114     DOI: 10.1007/s002130050761

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  14 in total

1.  The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior.

Authors:  K McFarland; P W Kalivas
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

2.  fMRI response in the medial prefrontal cortex predicts cocaine but not sucrose self-administration history.

Authors:  Hanbing Lu; Svetlana Chefer; Pradeep K Kurup; Karine Guillem; D Bruce Vaupel; Thomas J Ross; Anna Moore; Yihong Yang; Laura L Peoples; Elliot A Stein
Journal:  Neuroimage       Date:  2012-06-01       Impact factor: 6.556

Review 3.  Brain circuitry and the reinstatement of cocaine-seeking behavior.

Authors:  Peter W Kalivas; Krista McFarland
Journal:  Psychopharmacology (Berl)       Date:  2003-03-22       Impact factor: 4.530

Review 4.  The ventral pallidum: Subregion-specific functional anatomy and roles in motivated behaviors.

Authors:  David H Root; Roberto I Melendez; Laszlo Zaborszky; T Celeste Napier
Journal:  Prog Neurobiol       Date:  2015-04-06       Impact factor: 11.685

5.  Chemogenetic inhibition reveals midline thalamic nuclei and thalamo-accumbens projections mediate cocaine-seeking in rats.

Authors:  Amanda M Wunsch; Lindsay M Yager; Elizabeth A Donckels; Calvin T Le; John F Neumaier; Susan M Ferguson
Journal:  Eur J Neurosci       Date:  2017-07-26       Impact factor: 3.386

6.  Modulatory effects of Ampicillin/Sulbactam on glial glutamate transporters and metabotropic glutamate receptor 1 as well as reinstatement to cocaine-seeking behavior.

Authors:  Alaa M Hammad; Fawaz Alasmari; Yusuf S Althobaiti; Youssef Sari
Journal:  Behav Brain Res       Date:  2017-06-15       Impact factor: 3.332

Review 7.  The thalamus in drug addiction: from rodents to humans.

Authors:  Anna S Huang; Jameson A Mitchell; Suzanne N Haber; Nelly Alia-Klein; Rita Z Goldstein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-03-19       Impact factor: 6.237

Review 8.  Reward processing by the opioid system in the brain.

Authors:  Julie Le Merrer; Jérôme A J Becker; Katia Befort; Brigitte L Kieffer
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

9.  A sensitizing D-amphetamine dose regimen induces long-lasting spinophilin and VGLUT1 protein upregulation in the rat diencephalon.

Authors:  Steven R Boikess; Steven J O'Dell; John F Marshall
Journal:  Neurosci Lett       Date:  2009-11-20       Impact factor: 3.046

10.  The dopamine D1 receptor agonist and D2 receptor antagonist LEK-8829 attenuates reinstatement of cocaine-seeking in rats.

Authors:  Natasa Milivojevic; Igor Krisch; Dusan Sket; Marko Zivin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-05-07       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.